BDBM521625 US11149054, Compound 961

SMILES CC[C@]1(O)CC[C@]2(C)[C@H]3CC[C@]4(C)[C@H](CC[C@H]4[C@@H]3CC=C2C1)[C@H](C)CC[C@H](O)c1ccccc1

InChI Key InChIKey=YGTABYIOXCZRPI-DTFSDHDUSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 521625   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Sage Therapeutics

US Patent
LigandPNGBDBM521625(US11149054, Compound 961)
Affinity DataEC50:  180nMAssay Description:The whole-cell patch-clamp technique was used to investigate the effects of positive allosteric modulating activity of test compounds on GlunN1/GluN2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2A(Homo sapiens (Human))
Sage Therapeutics

US Patent
LigandPNGBDBM521625(US11149054, Compound 961)
Affinity DataEC50:  617nMAssay Description:The whole-cell patch-clamp technique was used to investigate the effects of positive allosteric modulating activity of test compounds on GlunN1/GluN2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent